These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 5584957

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.
    Pearson JM, Schultze AE, Schwartz KA, Scott MA, Davis JM, Roth RA.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):378-83. PubMed ID: 8764373
    [Abstract] [Full Text] [Related]

  • 23. A long-lasting, plasmin-activatable thrombin inhibitor aids clot lysis in vitro and does not promote bleeding in vivo.
    Sheffield WP, Eltringham-Smith LJ, Gataiance S, Bhakta V.
    Thromb Haemost; 2009 May; 101(5):867-77. PubMed ID: 19404540
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [The hirudin tolerance test].
    MARKWARDT F.
    Klin Wochenschr; 1959 Nov 01; 37():1142-3. PubMed ID: 14421337
    [No Abstract] [Full Text] [Related]

  • 28. Histochemical demonstration of thrombin using fluorogenic substrate.
    Oka K, Tanaka K.
    Thromb Res; 1959 Nov 01; 19(1-2):125-8. PubMed ID: 7444849
    [No Abstract] [Full Text] [Related]

  • 29. Identification of lipids in blood thromboplastin.
    BENTLEY HP.
    Proc Soc Exp Biol Med; 1962 Dec 01; 111():757-9. PubMed ID: 13967538
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The effect of hirudin, a potent antithrombin, on the thromboplastin generation test.
    Caldwell MJ.
    Thromb Diath Haemorrh; 1967 Feb 28; 17(1-2):256-63. PubMed ID: 5584957
    [No Abstract] [Full Text] [Related]

  • 32. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 28; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 33. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
    Boström SL, Hansson GF, Sarich TC, Wolzt M.
    Thromb Res; 2004 Feb 28; 113(1):85-91. PubMed ID: 15081569
    [Abstract] [Full Text] [Related]

  • 34. [Hemostasis insufficiency in thrombin blockade by Hirudin].
    WITTE S, SCHRICKER KT.
    Thromb Diath Haemorrh; 1962 Jul 15; 7():491-8. PubMed ID: 14007758
    [No Abstract] [Full Text] [Related]

  • 35. [The use of the specific thrombin inhibitor hirudin in diagnostic and biochemical studies].
    Walsmann P.
    Pharmazie; 1988 Nov 15; 43(11):737-44. PubMed ID: 3073391
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP, Bernat A, Gaich C, Herbert M.
    Thromb Haemost; 2002 Feb 15; 87(2):238-44. PubMed ID: 11858483
    [Abstract] [Full Text] [Related]

  • 38. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
    Boström SL, Hansson GF, Sarich TC, Wolzt M.
    Thromb Res; 2004 Feb 15; 113(1):85-91. PubMed ID: 15081569
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.